Short answer
PHIBRO ANIMAL HEALTH CORP (PAHC) filed an 8-K current report with the SEC on August 26, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Fiscal Q4 and FY2026 operating results announced for periods ended June 30, 2026.
PHIBRO ANIMAL HEALTH CORP 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Fiscal Q4 and FY2026 operating results announced for periods ended June 30, 2026
- FY2027 financial guidance provided for the year ending June 30, 2027
- Detailed results and guidance contained in furnished Exhibit 99.1 press release
- Information furnished under Regulation FD, not filed under Exchange Act Section 18purposes
Item EX-99.1 · Exhibit EX-99.1
- Fiscal 2026 sales $1,518.1M, up 17%, with Adjusted EBITDA $255.0M, up 39%, signaling strong post-MFA integration performance
- Adjusted diluted EPS $3.22, up 48%, despite interest expense rising 28% to $44.4M after a $300.0M interest-rate swap expired
- Fiscal 2027 guidance: sales $1.55B-$1.60B, Adjusted EBITDA $258M-$268M, adjusted EPS $3.41-$3.59
- Chicago Heights plant closure planned for summer 2027, affecting approximately 100 employees and potentially creating one-time charges
- Leverage remains material at 2.9x gross debt, with $737.9M total debt and $82.0M cash and short-term investments
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other PHIBRO ANIMAL HEALTH CORP 8-K filings
Get the next PAHC 8-K as it lands
Follow PAHC for push alerts, or ask the research agent what this filing means.